Reye's Syndrome: Causes, Symptoms & Emergency Treatment

Medically reviewed | Last reviewed: | Evidence level: 1A
Reye's syndrome is a rare but serious condition that causes swelling in the liver and brain. It primarily affects children and teenagers recovering from a viral infection, especially if they have taken aspirin. Since the connection between aspirin and Reye's syndrome was discovered in the 1980s, the condition has become extremely rare due to public health warnings against giving aspirin to children.
📅 Published:
🔄 Updated:
⏱️ Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in pediatric medicine

📊 Quick Facts About Reye's Syndrome

Incidence
<2 cases/year
in the US currently
Primary Age
4-14 years
most affected
Survival Rate
~80%
with early treatment
Key Risk Factor
Aspirin
during viral illness
Onset
3-5 days
after viral illness
ICD-10 Code
G93.7
Reye's syndrome

💡 The Most Important Things You Need to Know

  • Never give aspirin to children: Aspirin (acetylsalicylic acid) should never be given to anyone under 18 years old during viral infections unless prescribed by a doctor
  • Extremely rare today: Since public health warnings in the 1980s, Reye's syndrome has become extremely rare (fewer than 2 cases per year in the US)
  • Medical emergency: Reye's syndrome is a life-threatening condition that requires immediate intensive care treatment
  • Key warning signs: Persistent vomiting, lethargy, and confusion following a viral illness like flu or chickenpox
  • Safe alternatives exist: Use acetaminophen (paracetamol) or ibuprofen instead of aspirin for fever and pain in children
  • Early treatment is critical: Survival rates are approximately 80% with early diagnosis and aggressive treatment

What Is Reye's Syndrome?

Reye's syndrome is a rare but potentially fatal condition that causes acute swelling of the liver and brain. It primarily affects children and teenagers who are recovering from a viral infection, particularly if they have been treated with aspirin. The condition is named after Australian pathologist Dr. Ralph Douglas Reye, who first described it in 1963.

Reye's syndrome represents one of the most significant examples of how medical research and public health interventions can virtually eliminate a disease. In the early 1980s, the United States saw approximately 555 reported cases per year, with a mortality rate approaching 50%. Today, thanks to widespread public health campaigns warning against aspirin use in children, the condition has become exceedingly rare, with fewer than two cases reported annually in the United States.

The condition develops when the liver loses its ability to perform one of its most critical functions: detoxifying the blood. Under normal circumstances, the liver converts ammonia, a toxic byproduct of protein metabolism, into urea, which is then safely excreted through urine. When Reye's syndrome strikes, this process breaks down catastrophically. The liver cells become damaged and fatty, losing their ability to clear ammonia from the bloodstream.

As ammonia levels rise in the blood, the brain begins to suffer. Ammonia is highly toxic to brain tissue, causing swelling and increased pressure within the skull. This combination of liver failure and brain swelling explains the progression of symptoms seen in Reye's syndrome and why the condition can be fatal without prompt medical intervention.

The Connection to Viral Infections

Reye's syndrome typically develops as a complication following common viral infections. The most commonly associated viral illnesses include:

  • Influenza (flu): Both influenza A and B have been strongly linked to Reye's syndrome development
  • Varicella (chickenpox): One of the most commonly associated viral triggers
  • Common cold: Upper respiratory infections caused by various viruses
  • Gastroenteritis: Viral stomach flu can also precede Reye's syndrome

What makes Reye's syndrome particularly insidious is its timing. The condition typically emerges just as the child appears to be recovering from the viral illness. Parents may observe their child improving from the flu or chickenpox, only to see a sudden and severe decline in their condition 3-5 days later.

🚨 Critical Warning: Aspirin and Children

Never give aspirin (acetylsalicylic acid) to children or teenagers under 18 years of age, especially during viral infections like flu or chickenpox. This includes combination products containing aspirin. The only exception is when a doctor specifically prescribes aspirin for certain conditions like Kawasaki disease or after heart surgery.

What Causes Reye's Syndrome?

Reye's syndrome is caused by damage to cellular mitochondria in the liver and brain. The exact mechanism is not fully understood, but the condition is strongly associated with aspirin (acetylsalicylic acid) use during viral infections in children. Since aspirin warnings were issued in the 1980s, the incidence has dropped by over 99%.

The pathophysiology of Reye's syndrome involves damage to the mitochondria, the energy-producing structures within cells. When mitochondria are damaged, cells cannot produce adequate energy and begin to malfunction. In the liver, this leads to fatty infiltration and loss of normal metabolic function. In the brain, cellular damage leads to swelling and increased intracranial pressure.

Research has shown that aspirin appears to interfere with mitochondrial function, particularly in children who are fighting viral infections. The combination of viral illness and aspirin creates a "perfect storm" that can trigger the cascade of events leading to Reye's syndrome. However, the exact biochemical pathway remains incompletely understood, which is why some cases of Reye's syndrome occur even without documented aspirin exposure.

The Aspirin Connection

The link between aspirin and Reye's syndrome was established through epidemiological studies in the early 1980s. Multiple case-control studies demonstrated that children who developed Reye's syndrome were significantly more likely to have taken aspirin during their preceding viral illness compared to children who recovered normally.

The evidence was compelling enough that in 1986, the United States required warning labels on all aspirin-containing products, advising against their use in children and teenagers. Similar warnings were issued in countries worldwide. The result was dramatic: cases of Reye's syndrome plummeted from hundreds per year to single digits.

Historical Decline in Reye's Syndrome Cases (United States)
Time Period Approximate Cases per Year Key Events
1980-1982 555 cases/year (peak) Initial research linking aspirin to Reye's
1986 ~100 cases/year FDA requires aspirin warning labels
1990s ~20 cases/year Public awareness campaigns continue
2000-Present <2 cases/year Near-elimination of the condition

Other Potential Risk Factors

While aspirin is the most clearly established risk factor, researchers have identified several other factors that may play a role in Reye's syndrome development:

  • Underlying metabolic disorders: Some inherited metabolic conditions can present similarly to Reye's syndrome
  • Certain toxins: Exposure to some environmental toxins may increase risk
  • Genetic susceptibility: Some individuals may have genetic variations that make them more vulnerable
  • Other salicylates: Products containing salicylates (related to aspirin) may also pose risks

What Are the Symptoms of Reye's Syndrome?

The early symptoms of Reye's syndrome include persistent vomiting, unusual lethargy or sleepiness, and confusion. Symptoms typically appear 3-5 days after a viral illness begins to resolve. As the condition progresses, children may become combative, have seizures, or lose consciousness. Rapid deterioration is a hallmark of this condition.

Understanding the symptoms of Reye's syndrome is critical because early recognition and treatment can be life-saving. The condition progresses through distinct stages, and the speed of progression can vary from hours to days. Parents and caregivers should be vigilant for these warning signs, particularly in children recovering from viral infections.

The staging system for Reye's syndrome helps healthcare providers assess severity and guide treatment decisions. Early-stage symptoms may seem relatively mild, which can make diagnosis challenging. However, the condition can progress rapidly to life-threatening stages.

Early Warning Signs (Stage I)

The earliest symptoms of Reye's syndrome typically appear when a child seems to be recovering from a viral illness. These initial signs may be subtle and can be mistaken for continued effects of the original illness:

  • Persistent vomiting: Repeated vomiting that doesn't improve and seems unrelated to food intake
  • Unusual lethargy: Excessive tiredness or sleepiness beyond what's expected during illness recovery
  • Loss of energy: The child may seem listless and uninterested in normal activities
  • Diarrhea: Particularly in infants, along with rapid breathing

Progressive Symptoms (Stages II-III)

As Reye's syndrome progresses, neurological symptoms become more prominent as brain swelling worsens:

  • Personality changes: The child may become irritable, agitated, or aggressive
  • Confusion and disorientation: Difficulty recognizing familiar people or places
  • Combativeness: Uncharacteristic aggressive behavior
  • Delirium: Disturbed thinking and hallucinations
  • Hyperventilation: Rapid, deep breathing

Severe Symptoms (Stages IV-V)

Advanced Reye's syndrome represents a medical emergency with immediately life-threatening symptoms:

  • Seizures: Convulsions due to brain swelling
  • Loss of consciousness: Progressing to deep coma
  • Decerebrate posturing: Abnormal body positioning indicating severe brain damage
  • Respiratory failure: Breathing may become irregular or stop
🚨 Seek Emergency Medical Care Immediately If:
  • Your child has persistent vomiting after a viral illness
  • Your child is unusually sleepy or difficult to wake
  • Your child shows confusion or personality changes
  • Your child has seizures
  • Your child loses consciousness

Time is critical. Early treatment significantly improves outcomes. Find your emergency number →

How Is Reye's Syndrome Diagnosed?

There is no single definitive test for Reye's syndrome. Diagnosis is made by combining clinical presentation, blood tests showing liver dysfunction and elevated ammonia, and exclusion of other conditions. Key findings include elevated liver enzymes, low blood sugar, and elevated ammonia levels. Liver biopsy may show characteristic fatty infiltration.

Diagnosing Reye's syndrome presents significant challenges because its symptoms can mimic many other conditions. Healthcare providers must maintain a high index of suspicion, particularly in children who develop neurological symptoms following a viral illness. The diagnosis is typically made through a combination of clinical findings, laboratory tests, and exclusion of other possible causes.

The diagnostic process begins with a thorough medical history, with particular attention to recent viral illnesses and any medications the child has taken. A physical examination focuses on neurological status and signs of liver dysfunction. Laboratory testing then helps confirm or exclude the diagnosis.

Blood Tests

Several blood tests are critical in the evaluation of suspected Reye's syndrome:

  • Liver function tests: AST and ALT (liver enzymes) are typically elevated, often to very high levels
  • Ammonia levels: Blood ammonia is characteristically elevated, reflecting the liver's inability to clear this toxin
  • Blood glucose: Low blood sugar (hypoglycemia) is common, especially in younger children
  • Coagulation studies: Prothrombin time (PT) may be prolonged due to liver dysfunction
  • Bilirubin: Usually normal or only mildly elevated, which helps distinguish Reye's from other liver conditions

Imaging Studies

Brain imaging may be performed to assess the degree of brain swelling and rule out other causes of neurological symptoms:

  • CT scan of the brain: May show cerebral edema (brain swelling)
  • MRI of the brain: Provides more detailed images and may be used if the diagnosis is uncertain
  • Liver ultrasound: May show changes consistent with fatty infiltration

Liver Biopsy

In some cases, a liver biopsy may be performed to confirm the diagnosis. The characteristic finding is small-droplet fatty infiltration of liver cells (microvesicular steatosis) without significant inflammation. However, biopsy is not always necessary if the clinical picture and laboratory findings are consistent with Reye's syndrome.

Conditions That May Mimic Reye's Syndrome:

Several inherited metabolic disorders can present with similar symptoms and must be ruled out, including fatty acid oxidation disorders, urea cycle defects, and organic acidemias. These conditions may be identified through specialized metabolic testing.

How Is Reye's Syndrome Treated?

There is no specific cure for Reye's syndrome. Treatment focuses on intensive supportive care to protect the brain and support the liver while the body heals. This includes managing brain swelling with medications and procedures, maintaining blood sugar levels with IV glucose, and providing mechanical ventilation if needed. Early, aggressive treatment in an intensive care unit is essential.

The treatment of Reye's syndrome requires admission to a pediatric intensive care unit (PICU) where the child can receive close monitoring and aggressive supportive care. Because there is no specific antidote or cure for the condition, treatment focuses on managing complications and supporting vital organ functions while the body recovers.

The primary goals of treatment are to reduce brain swelling, prevent further liver damage, and maintain normal metabolic function. The prognosis depends heavily on how quickly treatment is initiated and the severity of the condition at the time of diagnosis.

Managing Brain Swelling

Cerebral edema (brain swelling) is the most dangerous complication of Reye's syndrome and requires aggressive management:

  • Intracranial pressure monitoring: A device may be placed to continuously measure pressure inside the skull
  • Mannitol: An osmotic diuretic given intravenously to reduce brain swelling
  • Hypertonic saline: May be used as an alternative to mannitol
  • Head elevation: Keeping the head of the bed elevated to 30 degrees helps reduce intracranial pressure
  • Controlled hyperventilation: May be used short-term to reduce brain swelling
  • Induced hypothermia: Cooling the body may help protect the brain in severe cases

Metabolic Support

Supporting the body's metabolic functions is critical during treatment:

  • Intravenous glucose: Given to maintain normal blood sugar levels and provide energy
  • Electrolyte management: Close monitoring and correction of electrolyte imbalances
  • Vitamin K: May be given if coagulation is impaired
  • Fresh frozen plasma: May be needed if bleeding occurs due to liver dysfunction

Respiratory Support

Many children with severe Reye's syndrome require mechanical ventilation to maintain adequate oxygenation and help control brain swelling through careful management of carbon dioxide levels.

Prognosis and Recovery

With early diagnosis and aggressive treatment, the survival rate for Reye's syndrome is approximately 80%. However, many survivors experience long-term neurological complications, which may include:

  • Learning disabilities and cognitive impairment
  • Speech and language difficulties
  • Motor coordination problems
  • Behavioral changes
  • Seizure disorders

The severity of long-term effects generally correlates with the severity of the acute illness. Children who are diagnosed and treated in the early stages typically have better outcomes than those who progress to later stages before treatment begins.

How Can Reye's Syndrome Be Prevented?

Prevention of Reye's syndrome is straightforward: never give aspirin or products containing aspirin to children or teenagers under 18 years old during viral infections. Safe alternatives for fever and pain include acetaminophen (paracetamol) and ibuprofen. Always check medication labels for salicylates, and consult a healthcare provider if unsure about any medication.

The dramatic decline in Reye's syndrome cases since the 1980s represents one of the great public health success stories. This near-elimination of the disease was achieved primarily through a simple intervention: educating parents and healthcare providers about the dangers of aspirin use in children during viral infections.

Understanding how to prevent Reye's syndrome is essential for every parent and caregiver. The guidelines are clear and easy to follow, yet awareness remains important because aspirin-containing products are still widely available.

Avoiding Aspirin in Children

The single most important prevention measure is avoiding aspirin and aspirin-containing products in children:

  • Never give aspirin to children under 18: This applies during viral infections such as flu, chickenpox, or cold
  • Check all medication labels: Aspirin may be listed as acetylsalicylic acid, salicylate, or acetylsalicylate
  • Be aware of combination products: Some cold and flu remedies contain aspirin
  • Ask about prescriptions: The only exception is when a doctor specifically prescribes aspirin for conditions like Kawasaki disease

Safe Alternatives for Fever and Pain

Parents have excellent alternatives to aspirin for managing fever and pain in children:

  • Acetaminophen (paracetamol): Safe for all ages when used according to dosing instructions
  • Ibuprofen: Safe for children over 6 months of age
  • Non-medication approaches: Cool compresses, rest, and adequate hydration
Medications That May Contain Aspirin:

Always check labels carefully. Products that may contain aspirin include some cold and flu remedies, certain stomach medications, and some anti-nausea products. Look for: aspirin, acetylsalicylic acid, salicylate, salicylic acid, and subsalicylate.

When Aspirin May Be Prescribed

There are specific medical conditions for which doctors may prescribe aspirin for children, despite the general warnings. These include:

  • Kawasaki disease: A condition causing inflammation of blood vessels
  • Following heart surgery: To prevent blood clots
  • Certain rheumatic conditions: Under specialist supervision

In these cases, the benefits of aspirin therapy outweigh the risks, and the child is typically monitored closely by healthcare providers.

Frequently Asked Questions About Reye's Syndrome

Medical References and Sources

This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.

  1. National Institutes of Health - MedlinePlus (2023). "Reye syndrome." https://medlineplus.gov/ency/article/001565.htm Comprehensive overview of Reye's syndrome from NIH.
  2. Centers for Disease Control and Prevention (CDC) (2023). "Reye's Syndrome Information." CDC Reye's Syndrome Public health information and statistics.
  3. American Academy of Pediatrics (2022). "Aspirin and Reye Syndrome." AAP guidance on aspirin avoidance in children.
  4. Reye RDK, Morgan G, Baral J (1963). "Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood." The Lancet. 282(7311):749-752. Original description of Reye's syndrome.
  5. Belay ED, et al. (1999). "Reye's syndrome in the United States from 1981 through 1997." New England Journal of Medicine. 340(18):1377-1382. PubMed Epidemiological study documenting decline in Reye's syndrome.
  6. Glasgow JF, Middleton B (2001). "Reye syndrome - insights on causation and prognosis." Archives of Disease in Childhood. 85(5):351-353. Review of pathophysiology and outcomes.

Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. The aspirin-Reye's syndrome link is supported by Level 1A evidence from multiple epidemiological studies.

⚕️

iMedic Medical Editorial Team

Specialists in pediatric medicine and neurology

Our Editorial Team

iMedic's medical content is produced by a team of licensed specialist physicians and medical experts with solid academic background and clinical experience. Our editorial team includes:

Pediatric Specialists

Licensed physicians specializing in pediatric medicine with experience in metabolic disorders and infectious diseases.

Neurologists

Specialists in pediatric neurology with expertise in brain disorders and intensive care management.

Researchers

Academic researchers with published peer-reviewed articles on pediatric conditions and metabolic disorders.

Medical Review

Independent review panel that verifies all content against international medical guidelines and current research.

Qualifications and Credentials
  • Licensed specialist physicians with international specialist competence
  • Members of AAP (American Academy of Pediatrics) and related organizations
  • Documented research background with publications in peer-reviewed journals
  • Continuous education according to WHO and international medical guidelines
  • Follows the GRADE framework for evidence-based medicine

Transparency: Our team works according to strict editorial standards and follows international guidelines for medical information. All content undergoes multiple peer review before publication.

iMedic Editorial Standards

📋 Peer Review Process

All medical content is reviewed by at least two licensed specialist physicians before publication.

🔍 Fact-Checking

All medical claims are verified against peer-reviewed sources and international guidelines.

🔄 Update Frequency

Content is reviewed and updated at least every 12 months or when new research emerges.

✏️ Corrections Policy

Any errors are corrected immediately with transparent changelog. Read more

Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in pediatrics, neurology, hepatology, and emergency medicine.